Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for 10x Genomics (TXG) over the last 7 years, with Q4 2025 value amounting to 0.08%.

  • 10x Genomics' Return on Invested Capital rose 1900.0% to 0.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.08%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.09% for FY2025, which is 1900.0% up from last year.
  • Latest data reveals that 10x Genomics reported Return on Invested Capital of 0.08% as of Q4 2025, which was up 1900.0% from 0.12% recorded in Q3 2025.
  • Over the past 5 years, 10x Genomics' Return on Invested Capital peaked at 0.07% during Q4 2021, and registered a low of 0.71% during Q1 2021.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.24% (2025), whereas its average is 0.29%.
  • Within the past 5 years, the most significant YoY rise in 10x Genomics' Return on Invested Capital was 6200bps (2021), while the steepest drop was -6000bps (2021).
  • 10x Genomics' Return on Invested Capital (Quarter) stood at 0.07% in 2021, then plummeted by -211bps to 0.22% in 2022, then crashed by -68bps to 0.37% in 2023, then rose by 24bps to 0.28% in 2024, then surged by 70bps to 0.08% in 2025.
  • Its Return on Invested Capital stands at 0.08% for Q4 2025, versus 0.12% for Q3 2025 and 0.14% for Q2 2025.